Compare drug alternatives
Aimovig® Alternatives
Aimovig®
(Erenumab)
Aimovig
-
Migraine
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig.
Aimovig is FDA approved for the following indications: Migraine prevention.
Emgality®
(Galcanezumab)
Emgality
-
Migraine
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Emgality is a medication that can be self-administered once a month by injecting it subcutaneously under the skin. It is used for migraine prevention in adults and can also be used to treat cluster headaches during a cluster headache period. The most frequently reported side effect is injection site reactions. Additionally, there are no known drug interactions with Emgality.
Emgality is FDA approved for the following indications: Migraine and Cluster Headaches.
Dosage & Administration
Administration
Subcutaneous
Subcutaneous
Dosing
70 mg once monthly or 140 mg once monthly (for some patients)
Migraine: 240 mg loading dose (120 mg x 2) followed by 120 mg monthly.
Latin Shorthand
70 mg/mo or 140 mg/mo
240 mg LD (120 mg x 2) then 120 mg/mo.
Financial Assistance
Copay
$5
$0
Annual Cap
Patient specific maximum benefit.
$4,900
Assistance Expiration
Calendar year
12 months
Generics
No lower-cost generic available
No lower-cost generic available